The Prize
Content
The Richard N. Merkin Prize in Biomedical Technology recognizes pathbreaking technologies that are demonstrably improving human health and the key individuals who contributed to their development. The prize illuminates the important work taking place across multiple disciplines, and in doing so supports and inspires continued innovation.
The Merkin Prize has an intentional focus on real-world impact, and a goal of shining a light on novel technologies and how these advances are transforming health care. It is administered by the Broad Institute of MIT and Harvard. The prize annually celebrates a novel technology and recognizes the key contributors, including individuals and teams, from anywhere in the world with a cash award of $400,000.